MACHIDA, S., SATO, T., FUJIWARA, H., SAGA, Y., TAKEI, Y., TANEICHI, A., . . . SUZUKI, M. (2012). Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma. D.A. Spandidos.

MACHIDA, SHIZUO, TOMOMI SATO, HIROYUKI FUJIWARA, YASUSHI SAGA, YUJI TAKEI, AKIYO TANEICHI, HIROAKI NONAKA, and MITSUAKI SUZUKI. Nedaplatin and Irinotecan Combination Therapy Is Equally Effective and Less Toxic Than Cisplatin and Irinotecan for Patients With Primary Clear Cell Adenocarcinoma of the Ovary and Recurrent Ovarian Carcinoma. D.A. Spandidos, 2012.

MACHIDA, SHIZUO, et al. Nedaplatin and Irinotecan Combination Therapy Is Equally Effective and Less Toxic Than Cisplatin and Irinotecan for Patients With Primary Clear Cell Adenocarcinoma of the Ovary and Recurrent Ovarian Carcinoma. D.A. Spandidos, 2012.